Investment supports accelerated development of precision, non-thermal focused ultrasound treatment of tumors and other oncology applications TORONTO, Ontario and HALIFAX, Nova Scotia -- July 27, 2026 -- The Cancer Breakthrough Fund, a mission-driven oncology-focused investment fund launched by founding partners the Terry Fox Foundation and Lumira Ventures, and backed by other partners...Read the Full Article
Just one year after launch, the Fund was oversubscribed with participation from leading Canadian cancer charities, impact investors, institutional investors and family offices. TORONTO – May 5, 2026 – Founding partners Lumira Ventures and the Terry Fox Foundation today announced an oversubscribed first close of the Cancer Breakthrough Fund, a first-of-its-kind-in-Canada, mission-driven...Read the Full Article
A first-of-its-kind collaboration in Canada between a philanthropic organization and a venture capital firm with a mission to invest in best-in-class cancer-focused companies. Toronto, ON – April 10, 2025 – The Terry Fox Foundation (“Terry Fox”) and Lumira Ventures (“Lumira”) have partnered to launch The Cancer Breakthrough Fund (the “Fund”). There is a growing recognition...Read the Full Article